Award recordCONTRACT

ALEXION PHARMACEUTICALS INC

PIID VA25614F0032· VHA· 256-NETWORK CONTRACT OFFICE 16· 6505 · DRUGS AND BIOLOGICALS· FY2014· $140,064 net obligations· UEI DKCXLGANZAN3· CT

Description

ECULIZUMAB 300MG/VIAL

First action · last action
2013-10-08 · 2015-01-23
Transactions
2
First transaction's obligation
$151,566
Base + all options value (sum of deltas)
$140,064
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D30015
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$151,566$0Base award · 2013-10-08 · this action $151,566 · running total $151,566Modification P00001 · 2015-01-23 · this action -$11,502 · running total $140,064
  • Base2013-10-08+$151,566= $151,566
  • Mod P000012015-01-23-$11,502= $140,064
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2013-10-08+$151,566$151,566ECULIZUMAB 300MG/VIAL
Mod P00001· OTHER ADMINISTRATIVE ACTION2015-01-23−$11,502$140,064ECULIZUMAB 300MG/VIAL

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DKCXLGANZAN3)

AwardOffice · PSC / listingNet obligationsFY
36E79726A0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C24526N0739245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$104,650FY2026
36F79726D0143NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26026F0055260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$1,255,805FY2026
36C26025F0093260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$626,866FY2025
36C26024F0096260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$522,487FY2024

Other recipients under 6505 from 256-NETWORK CONTRACT OFFICE 16 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25616P0619BIOCOMPATIBLES, INC.256-NETWORK CONTRACT OFFICE 16$147,500FY2016
VA25616E3628MCKESSON CORPORATION256-NETWORK CONTRACT OFFICE 16$17,878,985FY2016
VA25616F0536RETURNS 'R' US, LLC256-NETWORK CONTRACT OFFICE 16$0FY2016
VA25616P0541MCKESSON PLASMA AND BIOLOGICS LLC256-NETWORK CONTRACT OFFICE 16$10,851FY2016
VA25616P0522BIOCOMPATIBLES, INC.256-NETWORK CONTRACT OFFICE 16$32,000FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25614F0032_3600_V797D30015_3600 · retrieved 2026-09-26.